[Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
The authors are reporting results from a study about BK sensitivity among principal antituberculosis drugs in Benin Republic: 81.5% of them are susceptible for all specific antibiotics, 8.5% are offering resistance to INH and Streptomycin together. In this preliminary study no primitive resistance for RMP has been found.
Anagonou
S Y
SY
Laboratoire de Référence des Mycobactéries d'Akpakpa, Cotonou, République du Bénin.
Gninafon
M
M
Josse
R
R
Kinde-Gazard
D
D
Tawo
L
L
Foundohou
J
J
D001541:Benin; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000627:therapeutic use*; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D009161:Mycobacterium / Q000187:drug effects / Q000302:isolation & purification; D012293:Rifampin / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000382:microbiology*
D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Résistance initiale à la streptomycine, l'isoniazide, la rifampicine et l'éthambutol chez des malades tuberculeux bacillifères au Centre national de pneumo-phtisiologie à Cotonou (Bénin).